Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tonghua Limin Pharmaceutical is a Chinese pharmaceutical company headquartered in the "Medicine City" of Tonghua, Jilin Province. The company specializes in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern pharmaceutical products, with a particular expertise in sterile injection formulations. Its flagship product is the Ginseng Polysaccharide Injection, which is widely used as an adjuvant therapy in oncology to enhance immune function and mitigate the side effects of chemotherapy. Additionally, the company maintains a diverse portfolio of cardiovascular, anti-inflammatory, and respiratory treatments. Tonghua Limin operates large-scale GMP-certified production facilities and serves as a major supplier within the domestic Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tonghua Limin Pharmaceutical.